These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 20669948)

  • 1. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography.
    Wacker D; Fenalti G; Brown MA; Katritch V; Abagyan R; Cherezov V; Stevens RC
    J Am Chem Soc; 2010 Aug; 132(33):11443-5. PubMed ID: 20669948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-binding affinity of alternative conformers of human β
    Dilcan G; Doruker P; Akten ED
    Chem Biol Drug Des; 2019 May; 93(5):883-899. PubMed ID: 30637937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor.
    Zocher M; Fung JJ; Kobilka BK; Müller DJ
    Structure; 2012 Aug; 20(8):1391-402. PubMed ID: 22748765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Principles of Ligand Specificity on beta-2-adrenergic receptor.
    Chan HC; Filipek S; Yuan S
    Sci Rep; 2016 Oct; 6():34736. PubMed ID: 27703221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
    Tang H; Wang XS; Hsieh JH; Tropsha A
    Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
    Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
    J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
    Reynolds KA; Katritch V; Abagyan R
    J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models.
    Vilar S; Ferino G; Phatak SS; Berk B; Cavasotto CN; Costanzi S
    J Mol Graph Model; 2011 Feb; 29(5):614-23. PubMed ID: 21146435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking studies on a refined human beta(2) adrenoceptor model yield theoretical affinity values in function with experimental values for R-ligands, but not for S-antagonists.
    Soriano-Ursúa MA; Trujillo-Ferrara JG; Alvarez-Cedillo J; Correa-Basurto J
    J Mol Model; 2010 Mar; 16(3):401-9. PubMed ID: 19626351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bitopic Ligands Support the Presence of a Metastable Binding Site at the β
    Gaiser BI; Danielsen M; Xu X; Røpke Jørgensen K; Fronik P; Märcher-Rørsted E; Wróbel TM; Liu X; Mosolff Mathiesen J; Sejer Pedersen D
    J Med Chem; 2024 Jul; 67(13):11053-11068. PubMed ID: 38952152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.
    Vilar S; Karpiak J; Berk B; Costanzi S
    J Mol Graph Model; 2011 Apr; 29(6):809-17. PubMed ID: 21334234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of high affinity ligands for β2-adrenergic receptor through pharmacophore-based high-throughput virtual screening and docking.
    Yakar R; Akten ED
    J Mol Graph Model; 2014 Sep; 53():148-160. PubMed ID: 25137647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the β₂-adrenergic receptor is determined by conformational equilibrium in the transmembrane region.
    Kofuku Y; Ueda T; Okude J; Shiraishi Y; Kondo K; Maeda M; Tsujishita H; Shimada I
    Nat Commun; 2012; 3():1045. PubMed ID: 22948827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
    Plazinska A; Kolinski M; Wainer IW; Jozwiak K
    J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
    Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
    J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of intracellular allosteric β
    Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
    Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of an irreversible agonist-β(2) adrenoceptor complex.
    Rosenbaum DM; Zhang C; Lyons JA; Holl R; Aragao D; Arlow DH; Rasmussen SG; Choi HJ; Devree BT; Sunahara RK; Chae PS; Gellman SH; Dror RO; Shaw DE; Weis WI; Caffrey M; Gmeiner P; Kobilka BK
    Nature; 2011 Jan; 469(7329):236-40. PubMed ID: 21228876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.